Cargando…
Safety and Effectiveness of Evolocumab During Acute and Sub-acute Phases of Acute Coronary Syndrome (ACS): A Systematic Review and Meta-analysis
Background: Coronary artery disease (CAD), manifested mainly as acute coronary syndrome (ACS), continues to be a major cause of mortality globally and a significant contributing factor to the global disease burden. Elevation of low-density lipoprotein cholesterol levels attributed to proprotein conv...
Autores principales: | Alzarroug, Abdullah F, Al Gahtani, Haif K, Algahtani, Saad, Alghamdi, Hatan K, Alhinti, Mohammad F, Almutairi, Khalid A, Algahtani, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051038/ https://www.ncbi.nlm.nih.gov/pubmed/37007377 http://dx.doi.org/10.7759/cureus.35514 |
Ejemplares similares
-
Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients
por: Algahtani, Saad N., et al.
Publicado: (2022) -
Atrial Fibrillation as a Possible Adverse Reaction to Evolocumab
por: Abdelmaseih, Ramy, et al.
Publicado: (2021) -
Patterns of Dyslipidemia Among Acute Coronary Syndrome (ACS) Patients at a Tertiary Care Hospital in Lahore, Pakistan
por: Muneeb, Muhammad, et al.
Publicado: (2022) -
Correlation Between Different Parameters of Acute Myocardial Infarction and Obesity
por: Alqahtani, Saad A, et al.
Publicado: (2022) -
A Comparative Study of Ischemia-Modified Albumin: A Promising Biomarker for Early Detection of Acute Coronary Syndrome (ACS)
por: Jawade, Pranav, et al.
Publicado: (2023)